Slavica Stojnev

Ms. Slavica Stojnev

University of Nis, Faculty of medicine, Department of pathology
+1
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
NSNenad Stojiljkovic
Nenad Stojiljkovic
SISonja Ilic
Sonja Ilic
Vladimir JakovljevicVladimir Jakovljevic
Vladimir Jakovljevic
Nikola M StojanovićNikola M Stojanović
Nikola M Stojanović
SSSlavica Stojnev
Slavica Stojnev
Gordana KocicGordana Kocic
Gordana Kocic
Methotrexate is an antimetabolic drug with a myriad of serious side effects including nephrotoxicity, which presumably occurs due to oxidative tissue damage. Here, we evaluated the potential protective effect of lycopene, a potent antioxidant carotenoid, given in two different pharmaceutical forms in methotrexate‐induced kidney damage in rats. Serum biochemical (urea and creatinine) and tissue oxidative damage markers and histopathological kidney changes were evaluated after systemic administration of both lycopene dissolved in corn oil and lycopene encapsulated in nanoliposomes. Similar to previous studies, single dose of methotrexate induced severe functional and morphological alterations of kidneys with cell desquamation, tubular vacuolation, and focal necrosis, which were followed by serum urea and creatinine increase and disturbances of tissue antioxidant status. Application of both forms of lycopene concomitantly with methotrexate ameliorated changes in serum urea and creatinine and oxidative damage markers and markedly reversed structural changes of kidney tissue. Moreover, animals that received lycopene in nanoliposome‐encapsulated form showed higher degree of recovery than those treated with free lycopene form. The findings of this study indicate that treatment with nanoliposome‐encapsulated lycopene comparing to lycopene in standard vehicle has an advantage as it more efficiently reduces methotrexate‐induced kidney dysfunction.

6 April 2013 in Gastric Cancer
Verified
Journal Article
Closed access
PDF file
SSSlavica Stojnev
Slavica Stojnev
MKMiljan Krstić
Miljan Krstić
APAna Ristic Petrovic
Ana Ristic Petrovic
VSVladisav Stefanovic
Vladisav Stefanovic
THTakanori Hattori
Takanori Hattori

24 June 2019 in Medicina
Verified
Journal Article
Open access
PDF file
SSSlavica Stojnev
Slavica Stojnev
MKMiljan Krstić
Miljan Krstić
JKJovana Čukuranović Kokoris
Jovana Čukuranović Kokoris
ICIrena Conic
Irena Conic
Ivan Z PetkovićIvan Z Petković
Ivan Z Petković
LVLjubinka Janković Veličković
Ljubinka Janković Veličković
Background and objectives: Dysregulation of TGF-β signaling plays multiple roles in cancer development and progression. In the canonical TGF-β pathway, TGF-β regulates the expression of hundreds of target genes via interaction with Smads, signal transducers and transcriptional modulators. We evaluated the association of TGF-β1, Smad2, and Smad4, the key components of canonical TGFβ pathway, with clinicopathologic characteristics of urothelial bladder cancer, and assessed their prognostic value in prediction of patients’ outcome. Materials and Methods: Immunohistochemical analysis of TGF-β1, Smad2, and Smad4 expression was performed on 404 urothelial bladder cancer samples, incorporated in tissue microarrays. Expression status was correlated with clinicopathological and follow-up data. The median follow-up was 61 months. Results: High expression of TGF-β1, Smad2, and Smad4 was detected in 68.1%, 31.7% and 45.2% of the tumors, respectively. TGF-β1 overexpression was significantly associated with high tumor grade, and advanced pathologic stage (p < 0.001, respectively). Conversely, high Smad2 and Smad4 expression was linked to low tumor grade (p = 0,003, p = 0.048, respectively), and low tumor stage (p < 0.001, p = 0.003, respectively). Smad2 showed an inverse correlation with variant morphology and divergent differentiation of urothelial tumors (p = 0.014). High TGF-β1 correlated directly, while Smad2 and Smad4 correlated inversely to cancer-specific death (p = 0.043, p = 0.003, and p = 0.022, respectively). There was a strong relationship between Smad2 and Smad4 expression (p < 0.001). Survival analyses showed that high Smad2 and Smad4 expression was associated with longer overall survival (p = 0.003, p = 0.034, respectively), while in multivariate regression analysis TGF-β1 manifested as an independent predictor of poor outcome. Conclusions: Unraveling the complex roles and significance of TGF-β signaling in urothelial bladder cancer might have important implications for therapy of this disease. Assessment of TGF-β pathway status in patients with urothelial bladder cancer may provide useful prognostic information, and identify patients that could have the most benefit from therapy targeting TGF-β signaling cascade.

1 January 2013 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
SSSlavica Stojnev
Slavica Stojnev
APAna Ristic Petrovic
Ana Ristic Petrovic
LJLjubinka Jankovic-Velickovic
Ljubinka Jankovic-Velickovic
Projekat Ministarstva nauke Republike Srbije, br. 175092

1 January 2013 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
APAna Ristic Petrovic
Ana Ristic Petrovic
SSSlavica Stojnev
Slavica Stojnev
LJLjubinka Jankovic-Velickovic
Ljubinka Jankovic-Velickovic
GMGoran MARJANOVIĆ
Goran MARJANOVIĆ
Introduction. Malakoplakia is an unusual and very rare chronic inflammatory disease. In bladder especially it can mimic malignancy and lead to serious misdiagnosis. Case report. We presented a case of a middle-aged woman with persistent macrohematuria and cystoscopically polypoid bladder mass that resembled a neoplastic process. The final diagnosis was based on cystoscopic biopsy and microscopic findings of acidophilic, foamy histiocytes with the presence of Michaelis-Gutmann inclusions which are characteristic for diagnosis of malakoplakia. Immunohistochemistry confirmed diagnosis by demonstrating CD68-positive macrophages. Conclusion. Urinary bladder malakoplakia should be considered in patients with persistent urinary tract infections and tumor mass at cystoscopy. Early identification with prompt antibiotic treatment can be helpful in avoiding unnecessary surgical interventions and in preventing development of possible complications.

23 June 2019 in Medicina
Verified
Journal Article
Open access
PDF file
MKMiljan Krstić
Miljan Krstić
Nikola M StojanovićNikola M Stojanović
Nikola M Stojanović
SSSlavica Stojnev
Slavica Stojnev
GRGoran Radenkovic
Goran Radenkovic
JKJovana Čukuranović Kokoris
Jovana Čukuranović Kokoris
LVLjubinka Janković Veličković
Ljubinka Janković Veličković
Background and objectives: Gastric cancer (GC) is one of the deadliest malignancies, with the underlying pathophysiological mechanisms still not completely understood. In this study, we aimed to investigate the signal transducer and activator of transcription 3 (STAT3) moleculeconnection with the pathological features of GCs, and the expression of cell adhesive molecules (E-cadherin and β-catenin) and angiogenesis-related factors (vascular endothelial growth factor (VEGF), HIF1α, and CD31)). Materials and Methods: This study comprised 136 cases of GCs with data related to the patients’ demographic characteristics (age, gender) and pathological features (tumor location, gross type, Laurens’ type of GC, histological differentiation, invasion depth, lymphovascular invasion and the presence of metastases) which were correlated with STAT3 expression. Additionally, STAT3 expression and the expression of adhesive molecules and angiogenesis-related factors were studied by immunohistochemical methods. Results: The expression of STAT3 was found to be significantly associated with the occurrence of poorly differentiated GCs in the lower portion of the stomach and with the presence of distant metastases. Interestingly, none of the investigated parameters related to cell adhesion or to angiogenesis were found to be related to the expression of STAT3. Conclusions: The lack of significant differences between the studied STAT3 expression and some of the molecules associated with different cancer features might be due to the characteristics of the studied population sample associated with the origin, heterogeneity, and cancer pathophysiological background. Nonetheless, the results of our study suggest that STAT3 could be a useful marker for the presence of distant GC metastases, which further indicates that STAT3 action might involve some other signaling molecules/pathways that warrant further elucidation.